A Phase II Trial of Neoadjuvant Gemcitabine, Epirubicin, and Docetaxel as Primary Treatment of Patients With Locally Advanced or Inflammatory Breast Cancer-Reference-Cited by-同舟云学术

A Phase II Trial of Neoadjuvant Gemcitabine, Epirubicin, and Docetaxel as Primary Treatment of Patients With Locally Advanced or Inflammatory Breast Cancer

Published:2010-06 Issue:3 Volume:10 Page:217-223
ISSN:1526-8209
Container-title:Clinical Breast Cancer
language:en
Short-container-title:Clinical Breast Cancer

Author:

Yardley Denise A.,Peacock Nancy W.,Dickson Natalie R.,White Melissa B.,Vázquez Elizabeth R.,Foust John T.,Grapski Richard,Hendricks Linda K.,Scott William L.,Hainsworth John D.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference38 articles.

1. Indications for neoadjuvant chemotherapy for breast cancer;Bear;Semin Oncol,1998

2. Management of stage III primary breast cancer with primary chemotherapy, surgery, and radiation therapy;Hortobagyi;Cancer,1988

3. Comprehensive management of locally advanced breast cancer;Hortobagyi;Cancer,1990

4. Effect of preoperative chemotherapy on the outcome of women with operable breast cancer;Fisher;J Clin Oncol,1998

5. Randomized trial of chemoendocrine therapy started before or after surgery for treatment of primary breast cancer;Powles;J Clin Oncol,1995

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting protein quality control pathways in breast cancer;BMC Biology;2017-11-16

2. LEP rs7799039, LEPR rs1137101, and ADIPOQ rs2241766 and 1501299 Polymorphisms Are Associated With Obesity and Chemotherapy Response in Mexican Women With Breast Cancer;Clinical Breast Cancer;2017-10

3. Traitements systémiques des cancers du sein inflammatoires : un état des lieux;Bulletin du Cancer;2014-12

4. Triple-Negative Breast Cancer and the Need for New Therapeutic Targets;The American Journal of Pathology;2013-10

5. A phase 2 study of sequential neoadjuvant chemotherapy with gemcitabine and doxorubicin followed by gemcitabine and cisplatin in patients with large or locally advanced operable breast cancer: results from long-term follow-up;Breast Cancer;2012-02-22